Back to Table of Top Pathways

camptothecin

GeneID Mean_1 Mean_2 StDev_1 StDev_2 T-Statistic p-value SymbolDescription
1 79915 6.9 6.8 0.3 1.1 -0.201 0.8578 ATAD5 ATPase family, AAA domain containing 5
2 6311 9.4 9.3 0.4 0.2 -0.200 0.8535 ATXN2 ataxin 2
3 1544 5.9 4.8 0.3 0.4 -4.317 0.0144 CYP1A2 cytochrome P450, family 1, subfamily A, polypeptide 2
4 1557 2.5 2.6 0.1 0.3 0.024 0.9825 CYP2C19 cytochrome P450, family 2, subfamily C, polypeptide 19
5 1576 3.5 4.1 0.8 0.4 1.209 0.3145 CYP3A4 cytochrome P450, family 3, subfamily A, polypeptide 4
6 10919 10.5 10.1 0.2 0.2 -1.634 0.1776 EHMT2 euchromatic histone-lysine N-methyltransferase 2
7 9451 6.6 7.4 0.2 0.1 5.398 0.0116 EIF2AK3 eukaryotic translation initiation factor 2-alpha kinase 3
8 3043 2.4 2.6 0.0 0.1 2.234 0.1419 HBB hemoglobin, beta
9 3091 9.2 9.6 0.1 0.0 6.301 0.0241 HIF1A hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
10 3178 13.0 12.9 0.1 0.2 -0.603 0.5921 HNRNPA1 heterogeneous nuclear ribonucleoprotein A1
11 3028 14.1 14.3 0.1 0.3 0.880 0.4515 HSD17B10 hydroxysteroid (17-beta) dehydrogenase 10
12 3717 7.8 8.8 0.2 0.4 3.864 0.0427 JAK2 Janus kinase 2
13 688 6.8 9.6 0.3 0.6 7.729 0.0046 KLF5 Kruppel-like factor 5 (intestinal)
14 4170 10.3 10.5 0.4 0.0 0.927 0.4495 MCL1 myeloid cell leukemia 1
15 2475 8.9 9.4 0.0 0.2 4.269 0.0438 MTOR mechanistic target of rapamycin (serine/threonine kinase)
16 4780 3.0 2.7 0.8 0.3 -0.563 0.6169 NFE2L2 nuclear factor, erythroid 2-like 2
17 10392 6.1 6.9 0.3 0.2 4.327 0.0177 NOD1 nucleotide-binding oligomerization domain containing 1
18 64127 6.7 6.6 0.2 0.3 -0.502 0.6440 NOD2 nucleotide-binding oligomerization domain containing 2
19 1903 7.4 10.7 0.3 0.4 11.663 0.0005 S1PR3 sphingosine-1-phosphate receptor 3
20 55775 11.6 11.7 0.0 0.1 2.150 0.1386 TDP1 tyrosyl-DNA phosphodiesterase 1
21 7066 3.6 3.1 0.4 0.6 -1.093 0.3418 THPO thrombopoietin
22 7124 3.9 4.6 2.4 1.2 0.416 0.7063 TNF tumor necrosis factor
23 7150 10.7 11.0 0.1 0.1 3.898 0.0198 TOP1 topoisomerase (DNA) I